We raised fund from 66 mil shares to the current 145 mil to paid ATO and ANZ debt 2 years ago. Now we raise another 140 mil share to pay ATO+ANZ (the same debt we supposed to pay off already) AND Kerogen Facility. And Mr AC and management in annual report keep telling us we cutting overhead to reduce operational cost and increase profit margin, while contract revenue increasing and yet we have EBDTA loss in the last 3 years in a tune of $30+ mil. Can someone point out what is going on? where the money has gone?
Is there a another monument scheme some where here we are not aware of?
I got a feeling that small share holders are going to lose out on the Cuadrilla value sooner or later because of such imcompetence? or the wolves (within the management or bigger stake holder) are cirling in for the kill? Maybe someone here said was right UK shale is good investment potential but are we backing the right horse?
Maybe strong critics on this forum of the incompetence of management of AJL were right all along.
tgn01
- Forums
- ASX - By Stock
- AJL
- sale of 25% interest in bowland prospect
sale of 25% interest in bowland prospect, page-25
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AJL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.00M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 450104 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 1950945 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 450104 | 0.008 |
7 | 1755183 | 0.007 |
4 | 1245000 | 0.006 |
3 | 600000 | 0.005 |
1 | 500000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1950945 | 4 |
0.010 | 861278 | 3 |
0.011 | 135000 | 2 |
0.017 | 60000 | 1 |
0.019 | 12500 | 1 |
Last trade - 09.59am 11/10/2024 (20 minute delay) ? |
Featured News
AJL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online